Bache Iben, Hasle Henrik, Tommerup Niels, Olsen Jørgen H
Wilhelm Johannsen Centre for Functional Genome Research, Department of Medical Biochemistry and Genetics, University of Copenhagen, Denmark.
Genes Chromosomes Cancer. 2006 Mar;45(3):231-46. doi: 10.1002/gcc.20285.
We measured the occurrence of cancer in an unselected cohort of carriers of constitutional structural rearrangements in virtually complete nationwide registries for cancer and constitutional cytogenetic abnormalities. We identified 4,816 carriers of a constitutional structural rearrangement in the Danish Cytogenetic Registry and searched for cancer diagnoses by linkage to the Danish Cancer Registry. There was no overall increased risk for cancer among carriers (standardized incidence ratio [SIR], 0.96; 95% confidence interval [CI], 0.84-1.10), and no significant difference from that expected was found in balanced and unbalanced rearrangements or in any subtypes of rearrangements. We found significantly lower risks for carriers with rearrangements involving chromosome 21 (SIR, 0.50; 95% CI, 0.22-0.99) and for paternally inherited rearrangements (SIR, 0.30; 95% CI, 0.06-0.88). Risk estimates for the observed type-specific cancers showed an increased risk for non-Hodgkin lymphoma (SIR, 2.11; 95% CI, 1.09-3.69). However, subgroup analyses were not guided by study hypotheses, and our statistical evaluation of the data should be looked upon as exploratory. In addition, we found 12 constitutional structural rearrangements with a breakpoint potentially associated with a cancer-related gene. Potential new loci associated with type-specific cancers were suggested by the findings of families with more than one affected carrier and by the involvement of the same cytogenetic bands in unrelated carriers. Molecular mapping of these breakpoints might provide new insight into cancer predisposition.
我们在几乎完整的全国癌症和染色体结构异常登记处,对未经选择的具有染色体结构重排的携带者队列进行了癌症发生率的测量。我们在丹麦细胞遗传学登记处识别出4816名染色体结构重排的携带者,并通过与丹麦癌症登记处的关联搜索癌症诊断信息。携带者中癌症总体风险未增加(标准化发病率比[SIR]为0.96;95%置信区间[CI]为0.84 - 1.10),在平衡和不平衡重排或任何重排亚型中,与预期风险均无显著差异。我们发现涉及21号染色体的重排携带者(SIR为0.50;95% CI为0.22 - 0.99)以及父系遗传重排携带者(SIR为0.30;95% CI为0.06 - 0.88)的风险显著较低。观察到的特定类型癌症的风险估计显示非霍奇金淋巴瘤风险增加(SIR为2.11;95% CI为1.09 - 3.69)。然而,亚组分析并非基于研究假设,我们对数据的统计评估应视为探索性的。此外,我们发现12种染色体结构重排的断点可能与癌症相关基因有关。有多个受累携带者的家族研究结果以及无关携带者中相同细胞遗传学带的参与,提示了与特定类型癌症相关的潜在新位点。这些断点的分子图谱分析可能为癌症易感性提供新的见解。